Journal of Bioequivalence & Bioavailability

Applications of nanotechnology in drug delivery

International Conference and Exhibition on Biowaivers & Biosimilars

September 10-12, 2012 Hilton San Antonio Airport, USA

R.M. Khalil

Scientific Tracks Abstracts: J Bioequiv Availab

Abstract:

Sauerborn spent most of her undergrad years in well-known institutes such as the Centers for Disease Control and Prevention in Atlanta to widen her knowledge in immunology. After acquiring her Masters in Science she joined the lab of Prof. Schellekens and Prof. Jiskoot, two experts in immunogenicity of protein drugs, to shed more light on the immunological aspects of antibody formation against aggregated protein therapeutics. After obtaining her PhD she started a spin-off, ADA InVivo BV, a biotech CRO in the field of drug safety. Currently she is a project leader at the bioanalysis and immunogenicity department at TNO Triskelion BV, a Dutch CRO.

Biography :

R. M. Khalil is the Head of department of pharmaceutical technology, National Research Centre (NRC) Cairo, Egypt. She received her Ph.D in pharmaceutical science from College of Pharmacy, Cairo University in 1989. Dr. Khalil is a Member of the permanent scientific committee for promotion of research staff members, NRC, Principal investigator, CO-Principal Investigator and Participant in many research projects in NRC, member in Egyptian Association and Syndicate of Pharmacists in Egypt. She received ?Scientific Encouraging Prize of NRC? in 1998. Dr. Khalil has published more than 42 scientific papers.